Replies to post #511899 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Sorry pal, the FDA never allowed the trial to resume screening. That is why only 331 of the planned 348 were enrolled.

The difference between the numbers is minor, but the reason for the FDA hold is not.